Literature DB >> 26622907

Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case report.

Ana Cebollero DE Miguel1, Roberto Pazo Cid1, Javier Martinez Trufero1, Isabel Pajares Bernad1, Lourdes Calera Urquizu1, Jorge Hernando Cubero1, Antonio Anton Torres1.   

Abstract

Carcinomas of unknown primary origin account for 3-5% of all malignancies. The current literature suggests that metastatic dissemination is able to occur in the absence of primary tumor growth. In metastatic disease that is difficult to diagnose, the origin usually remains unknown even after an exhaustive evaluation of immunohistochemistry (IHC) markers. In the current study, a 49-year-old male presented with lymph nodes metastases of unknown origin. The excisional biopsy of an inguinal node revealed an adenocarcinoma growth pattern, but the IHC could not determine the primary origin. A gene profiling test was performed to complete the diagnosis and a salivary gland adenocarcinoma was diagnosed with 90% probability. Subsequently, the patient underwent appropriate chemotherapy for salivary gland adenocarcinoma, and exhibited an improved partial response. The present case study highlights the importance of an accurate diagnosis of the primary tumor and the use of all the current tools available in order to provide patients with the best treatment possible.

Entities:  

Keywords:  adenocarcinoma; cancer of unknown primary; gene expression profiling; salivary gland cancers

Year:  2015        PMID: 26622907      PMCID: PMC4580082          DOI: 10.3892/ol.2015.3572

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  26 in total

1.  Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin.

Authors:  A I Dreyfuss; J R Clark; B G Fallon; M R Posner; C M Norris; D Miller
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

2.  A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.

Authors:  John D Hainsworth; Catherine A Schnabel; Mark G Erlander; David W Haines; F Anthony Greco
Journal:  Clin Colorectal Cancer       Date:  2011-10-14       Impact factor: 4.481

3.  Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.

Authors:  A J van de Wouw; M L G Janssen-Heijnen; J W W Coebergh; H F P Hillen
Journal:  Eur J Cancer       Date:  2002-02       Impact factor: 9.162

4.  Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients.

Authors:  L Licitra; R Cavina; C Grandi; S D Palma; M Guzzo; R Demicheli; R Molinari
Journal:  Ann Oncol       Date:  1996-08       Impact factor: 32.976

Review 5.  Systemic therapy in the palliative management of advanced salivary gland cancers.

Authors:  Scott A Laurie; Lisa Licitra
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

6.  Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases.

Authors:  K Hamper; F Lazar; M Dietel; J Caselitz; J Berger; H Arps; U Falkmer; G Auer; G Seifert
Journal:  J Oral Pathol Med       Date:  1990-03       Impact factor: 4.253

7.  Molecular classification of human carcinomas by use of gene expression signatures.

Authors:  A I Su; J B Welsh; L M Sapinoso; S G Kern; P Dimitrov; H Lapp; P G Schultz; S M Powell; C A Moskaluk; H F Frierson; G M Hampton
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

8.  Sequential mediastinal lymphadenectomy of an unknown primary tumor.

Authors:  Hiroaki Harada; Yoshinori Yamashita; Kazuya Kuraoka; Kiyomi Taniyama
Journal:  Ann Thorac Surg       Date:  2013-02       Impact factor: 4.330

9.  An analysis of 1539 patients with cancer of unknown primary site.

Authors:  E Altman; E Cadman
Journal:  Cancer       Date:  1986-01-01       Impact factor: 6.860

Review 10.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

View more
  1 in total

Review 1.  Cancer of Unknown Primary: Challenges and Progress in Clinical Management.

Authors:  Noemi Laprovitera; Mattia Riefolo; Elisa Ambrosini; Christiane Klec; Martin Pichler; Manuela Ferracin
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.